Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2006
Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neckJean Bourhis, Fernando Rivera, Ricard Mesia, et al.Oral Oncology|September 20, 2022
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancerRicardo Hitt, Ricard Mesía, Alicia Lozano, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2021
Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancerSilvia Peña-Cabia, Ana Royuela Vicente, Ruth Ramos Díaz, et al.Cancer|March 22, 2012
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 studySusan Urba, Carla M L van Herpen, Tarini Prasad Sahoo, et al.The New England Journal of Medicine|September 12, 2008
Platinum-based chemotherapy plus cetuximab in head and neck cancerJan B Vermorken, Ricard Mesia, Fernando Rivera, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancerRicardo Hitt, Antonio López-Pousa, Javier Martínez-Trufero, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC GroupBenjamin Lacas, Alexandra Carmel, Cécile Landais, et al.Pageof 3